Akorn lays out $45M for Sunovion lung drug; Sanofi teams with Indian hospitals on diabetes clinics;

> Sunovion Pharmaceuticals said it would sell off rights to its respiratory drug Xoponex (levalbuterol) to Akorn ($AKRX) for $45 million. Release

> Sanofi ($SNY) teamed up with India's Apollo Hospitals on a diabetes-care program in India, delivered through a network of Apollo Sugar Clinics. Report

> Merck Serono tapped Hutchison China MediTech to market its beta blocker Ziac (bisoprolol HCl) in China. Report

> Pfizer Canada and WestJet launched a social media contest to raise awareness of anaphylaxis; Pfizer ($PFE) markets EpiPen in that country. Release

And Finally... Novo Nordisk ($NVO) and Diabetes UK started an awareness campaign, "Talk Hypos," to encourage diabetes patients to report hypoglycemia to their doctor or nurse. Release